公开(公告)号：US11731952B2

公开(公告)日：2023-08-22

申请号：US16633464

申请日：2018-08-29

Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT ,  LEUKOGENE THERAPEUTICS INCORPORATED

Inventor： Nathan G. Dolloff ,  Reeder M. Robinson ,  Allen B. Reitz ,  Haiyan Bian

IPC: C07C39/38 ,  C07C43/225 ,  C07C61/29 ,  C07C69/708 ,  C07C233/02 ,  C07C233/58 ,  C07D317/70 ,  C07D317/52 ,  C07D319/14 ,  C07D263/52 ,  C07C69/712 ,  A61P35/00 ,  C07C62/32 ,  C07C69/757 ,  C07C235/40 ,  C07C235/34 ,  C07C49/255 ,  C07C59/72 ,  C07C65/11

CPC classification number: C07D317/70 ,  A61P35/00 ,  C07C39/38 ,  C07C43/225 ,  C07C49/255 ,  C07C59/72 ,  C07C61/29 ,  C07C62/32 ,  C07C65/11 ,  C07C69/708 ,  C07C69/712 ,  C07C69/757 ,  C07C233/02 ,  C07C233/58 ,  C07C235/34 ,  C07C235/40 ,  C07D263/52 ,  C07D317/52 ,  C07D319/14 ,  C07C2601/14 ,  C07C2602/08

Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.

公开(公告)号：US20190062298A1

公开(公告)日：2019-02-28

申请号：US16115780

申请日：2018-08-29

Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT

Inventor： Nathan G. Dolloff ,  Reeder M. Robinson ,  Allen B. Reitz ,  Haiyan Bian

IPC: C07D317/70 ,  C07C39/38 ,  C07D319/14 ,  C07D263/52 ,  C07C69/712 ,  C07C59/72 ,  C07C62/32 ,  C07C69/757 ,  C07C235/40 ,  C07C235/34 ,  C07C49/255 ,  A61P35/00

CPC classification number: C07D317/70 ,  A61P35/00 ,  C07C39/38 ,  C07C43/225 ,  C07C49/255 ,  C07C59/72 ,  C07C62/32 ,  C07C65/11 ,  C07C69/708 ,  C07C69/712 ,  C07C69/757 ,  C07C235/34 ,  C07C235/40 ,  C07C2601/14 ,  C07C2602/08 ,  C07D263/52 ,  C07D319/14

Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.

公开(公告)号：US10329269B2

公开(公告)日：2019-06-25

申请号：US16115780

申请日：2018-08-29

Applicant: MUSC FOUNDATION FOR RESEARCH DEVELOPMENT

Inventor： Nathan G. Dolloff ,  Reeder M. Robinson ,  Allen B. Reitz ,  Haiyan Bian

IPC: C07D317/70 ,  C07C39/38 ,  C07D319/14 ,  C07D263/52 ,  C07C69/712 ,  A61P35/00 ,  C07C62/32 ,  C07C69/757 ,  C07C235/40 ,  C07C235/34 ,  C07C49/255 ,  C07C59/72

Abstract: The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.